Prognostic factors in pulmonary arterial hypertension: Literature review

被引:4
作者
Stepnowska, Emilia [1 ]
Lewicka, Ewa [2 ]
Dabrowska-Kugacka, Alicja [2 ]
Miekus, Pawel [1 ]
Raczak, Grzegorz [2 ]
机构
[1] St Vincent de Paul Hosp, Dept Cardiol, Gdynia, Poland
[2] Med Univ Gdansk, Dept Cardiol & Cardiac Electrotherapy, Gdansk, Poland
来源
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE | 2017年 / 26卷 / 03期
关键词
pulmonary arterial hypertension; prognosis; risk factor; mortality; BRAIN NATRIURETIC PEPTIDE; 6-MINUTE WALK DISTANCE; RIGHT-VENTRICULAR MASS; URIC-ACID; SURVIVAL; DISEASE; SCLERODERMA; MORTALITY; CORRELATE; SEVERITY;
D O I
10.17219/acem/61855
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Pulmonary arterial hypertension is a disease that has a bad influence on the patient's prognosis. Recently, the possibility of therapy has dramatically changed. Nowadays, the treatment of this disease is concerned mainly with the pathophysiological target. In clinical practice, it is important to start therapy at the appropriate time, when the patient is qualified because of an unsatisfactory examination result or improve therapy when the patient is getting worse. The understanding of prognosis factors in pulmonary arterial hypertension is necessary, because it is used to determine the length of patients' life expectancy. In September of 2015, new guidelines of ESC concerning the diagnosis and treatment of pulmonary hypertension have been presented. In our article we centered on the prognosis factor in pulmonary arterial hypertension. This document is a continuation of ESC guidelines. Many of the most contemporary articles are here summarized.
引用
收藏
页码:549 / 553
页数:5
相关论文
共 50 条
  • [21] Does arterial oxygenation during exercise add prognostic value in pulmonary arterial hypertension?
    Alsina-Restoy, Xavier
    Torres-Castro, Rodrigo
    Torralba-Garcia, Yolanda
    Burgos, Felip
    Albert Barbera, Joan
    Agusti, Alvar
    Blanco, Isabel
    RESPIRATORY MEDICINE, 2023, 206
  • [22] Prognostic role of traditional cardiovascular risk factors in patients with idiopathic pulmonary arterial hypertension
    Jonas, Kamil
    Waligora, Marcin
    Magon, Wojciech
    Zdrojewski, Tomasz
    Stokwiszewski, Jakub
    Ptazaki, Wojciech
    Podolec, Piotr
    Kopec, Grzegorz
    ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (06) : 1397 - 1406
  • [23] Assessing quality of life in pulmonary arterial hypertension: An independent prognostic marker
    Reeves, Glenn Edward Malcolm
    Shepherd, Julie
    Collins, Nicholas John
    Twaddell, Scott
    Harjit Singh, Rajinder
    PULMONARY CIRCULATION, 2024, 14 (02)
  • [24] Treatment goals in pulmonary arterial hypertension
    Savale, Laurent
    Sitbon, Olivier
    PRESSE MEDICALE, 2010, 39 : 1S33 - 1S40
  • [25] Prognostic factors in pulmonary arterial hypertension with Dana Point group 1
    Adachi, Shiro
    Hirashiki, Akihiro
    Nakano, Yoshihisa
    Shimazu, Shuzo
    Murohara, Toyoaki
    Kondo, Takahisa
    LIFE SCIENCES, 2014, 118 (02) : 404 - 409
  • [26] Quality of life as a prognostic marker in pulmonary arterial hypertension
    Caio JCS Fernandes
    Barbara CS Martins
    Carlos VP Jardim
    Rozana M Ciconelli
    Luciana K Morinaga
    Ana Paula Breda
    Susana Hoette
    Rogério Souza
    Health and Quality of Life Outcomes, 12
  • [27] Quality of life as a prognostic marker in pulmonary arterial hypertension
    Fernandes, Caio J. C. S.
    Martins, Barbara C. S.
    Jardim, Carlos V. P.
    Ciconelli, Rozana M.
    Morinaga, Luciana K.
    Breda, Ana Paula
    Hoette, Susana
    Souza, Rogerio
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2014, 12
  • [28] An Update on Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: a Review of the Current Literature
    Sundaram, Sneha M.
    Chung, Lorinda
    CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (02)
  • [29] Serum albumin concentration as an independent prognostic indicator in patients with pulmonary arterial hypertension
    Snipelisky, David
    Jentzer, Jacob
    Batal, Omar
    Dardari, Zeina
    Mathier, Michael
    CLINICAL CARDIOLOGY, 2018, 41 (06) : 782 - 787
  • [30] Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis
    Hoeper, Marius M.
    Pausch, Christine
    Olsson, Karen M.
    Huscher, Doerte
    Pittrow, David
    Gruenig, Ekkehard
    Staehler, Gerd
    Vizza, Carmine Dario
    Gall, Henning
    Distler, Oliver
    Opitz, Christian
    Gibbs, J. Simon R.
    Delcroix, Marion
    Ghofrani, H. Ardeschir
    Ewert, Ralf
    Kaemmerer, Harald
    Kabitz, Hans-Joachim
    Skowasch, Dirk
    Behr, Juergen
    Milger, Katrin
    Halank, Michael
    Wilkens, Heinrike
    Seyfarth, Hans-Juergen
    Held, Matthias
    Dumitrescu, Daniel
    Tsangaris, Iraklis
    Vonk-Noordegraaf, Anton
    Ulrich, Silvia
    Klose, Hans
    Claussen, Martin
    Eisenmann, Stephan
    Schmidt, Kai-Helge
    Rosenkranz, Stephan
    Lange, Tobias J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (07) : 971 - 981